Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Nanochon Chondrograft First in Human (FIH) Early Feasibility Study (EFS) - Panama

NCT: NCT07542184 · RECRUITING

NCT IDNCT07542184
StatusRECRUITING
Start Date2026-07-30
SponsorNanochon, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

The goal of this First in Human study is to learn if the Nanochon Chondrograft Implant is a safe primary surgical treatment for participants with cartilage lesions in the knee. This study will include males and females between the ages of 22 and 60.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑